Pro Medicus dividend and valuation

PME · ASX · AUD

Compare Pro Medicus
$187.76Change from previous close: −2.49%Absolute change: −$4.79

Close · November 20, 2026

Valuation

Pro Medicus paid $0.69 per share in dividends over the last 12 months (yield 0.4%). Last ex-dividend date: September 7, 2026. The P/E ratio is 76.0. The average price target of 15 analysts is $203.21.

Data as of November 22, 2026

Pro Medicus compared with similar companies

Pro Medicus's Forward P/E: 79.9, +208% against the median of a group of 5 similar companies (26.0).

Pro Medicus's metrics compared with similar companies
MetricPro MedicusMedian25th–75th percentileBand
Forward P/E79.926.023.5 – 79.9Middle
Price/book43.55.804.13 – 13.9High
Price/sales75.012.57.14 – 54.8High
Gross margin99.8%75.0%58.0% – 90.3%High
Operating margin74.9%19.5%-71.5% – 28.5%High
Net margin101.4%12.8%-6.3% – 25.2%High
ROE75.0%11.8%-19.8% – 14.1%High
Debt/equity0.000.080.02 – 0.70Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Pro Medicus: valuation over time

On the latest fiscal year's earnings (2026), Pro Medicus's P/E today is 74.0, below the median of its last 10 fiscal years (116.5; between 59.1 and 258.9 from 2017 to 2026). Relative to earnings, the stock costs less than it used to. The dividend yield (0.4%) is in line with the median of the last 10 fiscal years (0.4%).

Pro Medicus P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
Jun 2026$203.43$2.5480.2$0.690.3%
Jun 2025$285.08$1.10258.9$0.550.2%
Jun 2024$143.26$0.79181.1$0.400.3%
Jun 2023$65.64$0.58113.2$0.300.5%
Jun 2022$42.25$0.4299.4$0.220.5%
Jun 2021$58.72$0.30199.1$0.150.3%
Jun 2020$26.46$0.22119.7$0.120.5%
Jun 2019$25.29$0.18138.2$0.080.3%
Jun 2018$8.02$0.1084.4$0.060.7%
Jun 2017$5.32$0.0959.1$0.040.8%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$19.62B
Enterprise value
$19.37B
P/E (trailing 12 months)
76.0
PEG
2.67
EV/EBITDA
98.6
EV/revenue
74.0

Profitability and growth

ROA
25.8%
ROIC
34.4%
Revenue growth (year over year)
18.2%
Earnings growth (year over year)
48.4%

Financial health

Total cash
$252.28M
Total debt
$2.23M
Current ratio
6.85
Quick ratio
6.75

Dividends

Annual dividend per share
$0.69
Dividend yield
0.4%
Payout ratio
27.9%
Ex-dividend date
September 7, 2026

Analysts and estimates

Average price target
$203.21
Median price target
$222.00
High price target
$250.00
Low price target
$60.00
Analysts with a price target
15
Consensus
Buy
Forward EPS
$2.35
EPS estimate, current year
$1.88

Shares and trading

Beta
0.63
Average volume
202.41K
Shares outstanding
104.47M
Float
53.32M
Institutional ownership
25.9%
Insider ownership
49.0%